Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Hikma Pharmaceutical - Director/PDMR Shareholding

RNS Number : 6382L

Hikma Pharmaceuticals Plc

15 December 2025

 

Hikma Pharmaceuticals PLC

(the "Company")

LONDON, 15 December 2025: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI: 549300BNS685UXH4JI75) announces it has been notified of the following transactions by Persons Discharging Managerial Responsibilities ("PDMRs") of the Company.

This notification is made under Article 19(1) of the EU Market Abuse Regulation 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). The information set out below is provided in accordance with the requirements of Article 19(3) of MAR.

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities

Said Darwazah

1Details of the person discharging managerial responsibilities / person closely associated
a)NameSaid Darwazah
2Reason for the notification
a)Position/statusExecutive Chairman and CEO
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameHikma Pharmaceuticals PLC
b)LEI549300BNS685UXH4JI75
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionRelease of a pledge Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank Julius Baer. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman and CEO, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionGrant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of EFG International Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman and CEO, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
Mazen Darwazah
1Details of the person discharging managerial responsibilities / person closely associated
a)NameMazen Darwazah
2Reason for the notification
a)Position/statusExecutive Vice Chairman
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameHikma Pharmaceuticals PLC
b)LEI549300BNS685UXH4JI75
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionRelease of a pledge Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank Julius Baer. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionGrant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of EFG International Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
Ali Al-Husry
1Details of the person discharging managerial responsibilities / person closely associated
a)NameAli Al-Husry
2Reason for the notification
a)Position/statusNon-Executive Director
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameHikma Pharmaceuticals PLC
b)LEI549300BNS685UXH4JI75
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionRelease of a pledge Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank Julius Baer. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument and identification codeDescription: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)Nature of the transactionGrant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of EFG International Bank. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold Limited.
c)Price(s) and volume(s)Price(s): £0.00
Volume(s): 1,000,000
d)Aggregated informationAggregated volume: 1,000,000
Price: £0.00
e)Date of the transaction12 December 2025
f)Place of the transactionAmman, Jordan
  Helen Middlemist Group Company Secretary +44 (0) 20 7399 2760       This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHBUBDDLUBDGUU

Recent news on Hikma Pharmaceuticals

See all news